The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings

3 verified updates • corroborated by 3 independent sources • tracked since August 05, 2026

🔵
Aug 05, 06:00 PM 1 source: MarketWatch
How Ozempic maker Novo Nordisk blew its lead in GLP-1 weight-loss drugs. Can Europe compete in the high-stakes global economy?
🟡
Aug 06, 02:30 PM 1 source: cnbc.com
The divide between Eli Lilly and Novo Nordisk is widening after their latest earnings
🟡
Aug 06, 03:30 PM 1 source: CNBC